Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Speakers

Meet Our Esteemed Speakers

Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.

Biomarkers Speakers

13 - 14 June 2024 | London, UK

Gene Therapy Development 2024

Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Avencia Sanchez-Mejias
Chief Executive Officer and Co-Founder,
Integra Therapeutics
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Giandomenico Turchiano
Associate Director,
UCL/AstraZeneca
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
AskBio
Show More Speakers
Hide Speakers

All Speakers

Alberto del Rio Espinola
Director,
GentiBio Inc
Alex Bloom
Senior Vice President & Technical Operations,
Aviadobio
Amin Hajitou
Professor, Reader in Neuroinflammation,
Imperial College London
Breech Conrad Odu
Process Development Scientist,
Merck Life Sciences
Claire Kerridge
Head of Gene Therapy,
MHRA
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
Elina Hessels
Associate Director Analytical Platforms,
uniQure
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director of PD/MSAT,
Barinthus Biotherapeutics
James Norton
director Analytical development,
Meiragtx
Jane Kinghorn
Director Translational Research Office,
University College London
Johnson Varghese
Vice President, Head of Analytical Research and Development,
Beam Therapeutics
Khalid Saeed
Senior Scientist,
AstraZeneca
Koval Smith
Senior Manager DS/DP of Manufacturing, Science & Technologies,
Orchard Therapeutics
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Lily Li
Lead Scientist, Analytical Development,
Aviadobio
Michel Degueldre
Lead GT Biophysical Sciences,
UCB
Nina Kotsopoulou
Chief Technology Officer,
Xap Therapeutics
Otmane Boussif
Chief Technology Officer,
Anjarium Biosciences
Pamela Whalley
ASSOCIATE DIRECTOR CMC,
Complement therapeutics
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Roche
Paul Carter
Senior Director of Manufacturing, Science & Technologies,
Quell Therapeutics
Peter Pechan
Head of Vector Biology and Discovery,
UCB Biosciences
Rodolphe Clerval
Chief Executive Officer,
Coave Therapeutics
Victor Dillard
Vice President, Strategy & Operations,
Resolution Therapeutics
Vinciane De Cupere
Technical Lead Gene Therapy,
UCB
Yu-Tsan Liu
Senior Scientist,
UCB Pharma

06 - 08 November 2024 | London, UK

Cell & Gene 2024

Anna Nowocin
Head of Flow Cytometry Standardisation,
MHRA
Ibon Garitaonandia
Chief Scientific Officer,
CellProthera
Julia Matilainen
Head of Patient Operations CGT,
Roche
Kyle Zingaro
Head of Gene Therapy Process Sciences,
UCB
Lindsay Davies
Chief Scientific Officer,
NextCell Pharma AB
Muhammad Akram
Senior Medical Director,
Legend Biotech
Paolo Morgese
Vice President Public Affairs Europe,
Alliance for Regenerative Medicine
Rolf Koehler
Associate Director / Group Head,
Novartis
Ruben Rizzi
VP Global Regulatory Affairs,
BioNTech SE
Sarah Albon
CCTL Director,
Cambride University Hospitals NHSFT
Theodora Weisz
Head of Patient Advocacy and Public Affairs EMEA,
Novartis
Tim Allsopp
Chief Technology Officer,
Laverock Therapeutics
Show More Speakers
Hide Speakers

All Speakers

Aisling McMahon
Professor of Law,
Maynooth University
Aline Miller
Principal Investigator, Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation,
University of Manchester
Anton Hutter
Partner, Patent Attorney,
Venner Shipley IP
Charlotte Wilding
Patent Attorney,
Venner Shipley
Darren Nesbeth
Associate Professor,
UCL
Djordje Djordjevic
Co-founder + CEO,
Plurify
Dorothea Ledergerber
,
Independent
Elena Piletska
Associate Professor in Bioanalytical Chemistry,
University of Leicester
Eli Gilsohn
VP Intellectual Propery,
Resolution Therapeutics
Francesco Dazzi
Executive Medical Lead Cell Therapies,
AstraZeneca
Gabriel Kent
Analytical Development Scientist,
Resolution Therapeutics
Jas Uppal
Founder and CEO,
BQP Consultancy
Jim (James) Carlson
Principle Safety Director ATMP Enablement,
Roche
Luis Fernando Ayala Solares
Scientist - Cell Culture Media Development,
Merck Group
Luz Alonso-Crisostomo
Senior Scientist,
AstraZeneca
Manuel Carrondo
Vice-President,
iBET
Marc Schneider
Director ProductSupply Cell & Gene,
BioNTech
Matthew Gibson
Professor,
University of Manchester
Menasheh Fogel
IT Head, Cell and Gene Therapy,
Bayer
Millie Fox
Senior Scientist,
AstraZeneca
Molly Stevens
Professor at Oxford University & Research Director for Biomedical Materials,
Imperial College London
Monica Raimo
Sr. R&D Manager,
Glycostem Therapeutics
Nicolas Weber
Quality Team Leader,
Novartis Pharma
Patrizia Ferretti
Professor of Regenerative Biology,
University College London
Rahul Khetan
Venture Capital Associate,
UCB Ventures
Ruth Faram
Co-Founder & Chief Scientific Officer,
HigherSteaks
Sakis Mantalaris
Professor,
Trinity College Dublin & NIBRT
Sarah Snykers
Director of Operations,
Legend Biotech
Sarah Howlett
Associate Director,
AstraZeneca
Sergey Piletsky
Professor,
University of Leicester
Simon Chandler
CEO,
Rinri Therapeutics
Stephen Sullivan
Chief Operating Officer & Board Member,
iPSirius
Subhankar Mukhopadhyay
Senior Lecturer/Associate Professor,
King's College London
Ulrich Dr. Rümenapp
Senior Biotech Program Lead,
Bayer AG
Vicki Coutinho
Managing Director & Consultant,
Geni Consulting